Figure S7 from Fibronectin Contributes to a BRAF Inhibitor–driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2
Year: 2025
Type: other
Abstract: Figure S7. In the CUTC60-PDX model, BRAF and ERK1/2 inhibition have no significant effect on invasion.
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4416739783
Cites:
Cited by:
Related to: